Compare IRON & LRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IRON | LRN |
|---|---|---|
| Founded | 2017 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Other Consumer Services |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.6B | 3.5B |
| IPO Year | 2020 | 2007 |
| Metric | IRON | LRN |
|---|---|---|
| Price | $87.40 | $77.07 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 13 | 3 |
| Target Price | ★ $126.77 | $102.50 |
| AVG Volume (30 Days) | ★ 1.4M | 1.1M |
| Earning Date | 11-05-2026 | 10-20-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 20.00 |
| EPS | N/A | ★ 1.45 |
| Revenue | N/A | ★ $917,734,000.00 |
| Revenue This Year | N/A | $2.10 |
| Revenue Next Year | N/A | $4.63 |
| P/E Ratio | ★ N/A | $52.97 |
| Revenue Growth | N/A | ★ 3.29 |
| 52 Week Low | $40.00 | $60.61 |
| 52 Week High | $99.50 | $103.67 |
| Indicator | IRON | LRN |
|---|---|---|
| Relative Strength Index (RSI) | 65.42 | 45.67 |
| Support Level | $65.04 | $75.83 |
| Resistance Level | N/A | $84.08 |
| Average True Range (ATR) | 3.82 | 2.81 |
| MACD | 0.55 | -0.16 |
| Stochastic Oscillator | 97.64 | 42.47 |
Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs), including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.
Stride Inc is a technology company providing an educational platform to deliver proprietary and third-party curriculum, software systems, and educational services designed to facilitate individualized learning for students and adults throughout the U.S. The platform delivers products and services to attract, enroll, educate, track progress, and support students. It provides customized solutions to public and private schools, school districts, charter boards, employers, government agencies, and consumers. Its platform addresses two markets in the K-12 space: General Education and Career Learning, with products and services for the General Education market predominantly focused on core subjects for kindergarten through twelfth grade students.